losartan and oligonucleotides

losartan has been researched along with oligonucleotides in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Browatzki, M; Kranzhöfer, R; Kübler, W; Schmidt, J	1

Other Studies

1 other study(ies) available for losartan and oligonucleotides

Article	Year
Angiotensin II activates the proinflammatory transcription factor nuclear factor-kappaB in human monocytes. Biochemical and biophysical research communications, 1999, Apr-21, Volume: 257, Issue:3 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Arteriosclerosis; Binding, Competitive; Cell Separation; Consensus Sequence; Humans; Inflammation; Losartan; Lymphocytes; Monocytes; NF-kappa B; NF-kappa B p50 Subunit; Oligonucleotides; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Time Factors; Transcription Factor RelA; Tumor Necrosis Factor-alpha	1999

Article

Year

Angiotensin II activates the proinflammatory transcription factor nuclear factor-kappaB in human monocytes.

Biochemical and biophysical research communications, 1999, Apr-21, Volume: 257, Issue:3

Topics: Angiotensin II; Angiotensin Receptor Antagonists; Arteriosclerosis; Binding, Competitive; Cell Separation; Consensus Sequence; Humans; Inflammation; Losartan; Lymphocytes; Monocytes; NF-kappa B; NF-kappa B p50 Subunit; Oligonucleotides; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Time Factors; Transcription Factor RelA; Tumor Necrosis Factor-alpha

1999